Skip to main content
FDA OKs removal of safety warning from Smith & Nephew's Regranex gel

The FDA has approved removal of a safety warning on the label of Smith & Nephew's Regranex gel that noted "increased rate of mortality secondary to malignancy." The decision came after several studies showed no increased safety risk from Regranex, which is indicated to treat lower extremity diabetic neuropathic ulcers.

Full Story: